vs
ASPEN AEROGELS INC(ASPN)与Cytek Biosciences, Inc.(CTKB)财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是ASPEN AEROGELS INC的1.5倍($62.1M vs $41.3M),Cytek Biosciences, Inc.净利率更高(-70.9% vs -176.4%,领先105.4%),Cytek Biosciences, Inc.同比增速更快(8.1% vs -66.4%),ASPEN AEROGELS INC自由现金流更多($13.7M vs $-1.8M),过去两年Cytek Biosciences, Inc.的营收复合增速更高(17.7% vs -33.9%)
Aspen Aerogels Inc是全球领先的气凝胶基高性能隔热及热管理材料生产商,产品广泛应用于可再生能源、油气基础设施、航空航天、商业建筑与工业制造领域,核心市场覆盖北美、欧洲及亚太地区,旗下材料以优异的耐热性、防火性能和轻量化特性广受客户认可。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。
ASPN vs CTKB — 直观对比
营收规模更大
CTKB
是对方的1.5倍
$41.3M
营收增速更快
CTKB
高出74.5%
-66.4%
净利率更高
CTKB
高出105.4%
-176.4%
自由现金流更多
ASPN
多$15.4M
$-1.8M
两年增速更快
CTKB
近两年复合增速
-33.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $41.3M | $62.1M |
| 净利润 | $-72.9M | $-44.1M |
| 毛利率 | -55.5% | 52.9% |
| 营业利润率 | -170.3% | -9.0% |
| 净利率 | -176.4% | -70.9% |
| 营收同比 | -66.4% | 8.1% |
| 净利润同比 | -741.7% | -557.1% |
| 每股收益(稀释后) | $-0.87 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASPN
CTKB
| Q4 25 | $41.3M | $62.1M | ||
| Q3 25 | $73.0M | $52.3M | ||
| Q2 25 | $78.0M | $45.6M | ||
| Q1 25 | $78.7M | $41.5M | ||
| Q4 24 | $123.1M | $57.5M | ||
| Q3 24 | $117.3M | $51.5M | ||
| Q2 24 | $117.8M | $46.6M | ||
| Q1 24 | $94.5M | $44.9M |
净利润
ASPN
CTKB
| Q4 25 | $-72.9M | $-44.1M | ||
| Q3 25 | $-6.3M | $-5.5M | ||
| Q2 25 | $-9.1M | $-5.6M | ||
| Q1 25 | $-301.2M | $-11.4M | ||
| Q4 24 | $11.4M | $9.6M | ||
| Q3 24 | $-13.0M | $941.0K | ||
| Q2 24 | $16.8M | $-10.4M | ||
| Q1 24 | $-1.8M | $-6.2M |
毛利率
ASPN
CTKB
| Q4 25 | -55.5% | 52.9% | ||
| Q3 25 | 28.5% | 52.7% | ||
| Q2 25 | 32.4% | 52.3% | ||
| Q1 25 | 29.0% | 48.6% | ||
| Q4 24 | 38.3% | 58.5% | ||
| Q3 24 | 41.8% | 56.3% | ||
| Q2 24 | 43.8% | 54.6% | ||
| Q1 24 | 37.2% | 51.3% |
营业利润率
ASPN
CTKB
| Q4 25 | -170.3% | -9.0% | ||
| Q3 25 | -4.6% | -17.6% | ||
| Q2 25 | -6.6% | -23.3% | ||
| Q1 25 | -380.2% | -36.1% | ||
| Q4 24 | 12.0% | 5.2% | ||
| Q3 24 | 14.8% | -8.2% | ||
| Q2 24 | 17.0% | -18.3% | ||
| Q1 24 | 2.6% | -23.9% |
净利率
ASPN
CTKB
| Q4 25 | -176.4% | -70.9% | ||
| Q3 25 | -8.7% | -10.5% | ||
| Q2 25 | -11.6% | -12.2% | ||
| Q1 25 | -382.7% | -27.5% | ||
| Q4 24 | 9.2% | 16.8% | ||
| Q3 24 | -11.1% | 1.8% | ||
| Q2 24 | 14.3% | -22.4% | ||
| Q1 24 | -1.9% | -13.8% |
每股收益(稀释后)
ASPN
CTKB
| Q4 25 | $-0.87 | — | ||
| Q3 25 | $-0.08 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-3.67 | — | ||
| Q4 24 | $0.15 | — | ||
| Q3 24 | $-0.17 | — | ||
| Q2 24 | $0.21 | — | ||
| Q1 24 | $-0.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $156.9M | $90.9M |
| 总债务越低越好 | $65.5M | — |
| 股东权益账面价值 | $235.5M | $341.7M |
| 总资产 | $406.7M | $461.5M |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势,按日历期对齐
现金及短期投资
ASPN
CTKB
| Q4 25 | $156.9M | $90.9M | ||
| Q3 25 | $150.7M | $93.3M | ||
| Q2 25 | $167.6M | $75.5M | ||
| Q1 25 | $192.0M | $95.3M | ||
| Q4 24 | $220.9M | $98.7M | ||
| Q3 24 | $113.5M | $162.3M | ||
| Q2 24 | $91.4M | $177.9M | ||
| Q1 24 | $101.5M | $168.8M |
总债务
ASPN
CTKB
| Q4 25 | $65.5M | — | ||
| Q3 25 | $70.1M | — | ||
| Q2 25 | $77.3M | — | ||
| Q1 25 | $95.4M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $93.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
ASPN
CTKB
| Q4 25 | $235.5M | $341.7M | ||
| Q3 25 | $305.7M | $378.6M | ||
| Q2 25 | $308.8M | $377.6M | ||
| Q1 25 | $314.8M | $379.6M | ||
| Q4 24 | $614.7M | $395.7M | ||
| Q3 24 | $507.6M | $385.5M | ||
| Q2 24 | $517.8M | $389.1M | ||
| Q1 24 | $491.2M | $392.6M |
总资产
ASPN
CTKB
| Q4 25 | $406.7M | $461.5M | ||
| Q3 25 | $491.4M | $494.9M | ||
| Q2 25 | $525.1M | $493.3M | ||
| Q1 25 | $555.0M | $482.6M | ||
| Q4 24 | $895.1M | $499.5M | ||
| Q3 24 | $782.6M | $491.2M | ||
| Q2 24 | $748.6M | $483.7M | ||
| Q1 24 | $698.0M | $492.1M |
负债/权益比
ASPN
CTKB
| Q4 25 | 0.28× | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $16.1M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | $13.7M | $-1.8M |
| 自由现金流率自由现金流/营收 | 33.1% | -2.9% |
| 资本支出强度资本支出/营收 | 6.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-4.6M | $-8.8M |
8季度趋势,按日历期对齐
经营现金流
ASPN
CTKB
| Q4 25 | $16.1M | $-771.0K | ||
| Q3 25 | $15.0M | $-3.9M | ||
| Q2 25 | $-3.9M | $108.0K | ||
| Q1 25 | $5.6M | $-125.0K | ||
| Q4 24 | $35.7M | $2.0M | ||
| Q3 24 | $20.8M | $13.2M | ||
| Q2 24 | $6.8M | $6.2M | ||
| Q1 24 | $-17.7M | $4.0M |
自由现金流
ASPN
CTKB
| Q4 25 | $13.7M | $-1.8M | ||
| Q3 25 | $5.9M | $-4.6M | ||
| Q2 25 | $-16.8M | $-1.5M | ||
| Q1 25 | $-7.4M | $-974.0K | ||
| Q4 24 | $20.9M | $1.1M | ||
| Q3 24 | $-50.0K | $12.2M | ||
| Q2 24 | $-18.0M | $5.2M | ||
| Q1 24 | $-43.6M | $3.4M |
自由现金流率
ASPN
CTKB
| Q4 25 | 33.1% | -2.9% | ||
| Q3 25 | 8.1% | -8.7% | ||
| Q2 25 | -21.6% | -3.2% | ||
| Q1 25 | -9.4% | -2.3% | ||
| Q4 24 | 17.0% | 1.9% | ||
| Q3 24 | -0.0% | 23.7% | ||
| Q2 24 | -15.3% | 11.0% | ||
| Q1 24 | -46.1% | 7.6% |
资本支出强度
ASPN
CTKB
| Q4 25 | 6.0% | 1.6% | ||
| Q3 25 | 12.5% | 1.3% | ||
| Q2 25 | 16.5% | 3.5% | ||
| Q1 25 | 16.5% | 2.0% | ||
| Q4 24 | 12.0% | 1.6% | ||
| Q3 24 | 17.7% | 2.0% | ||
| Q2 24 | 21.1% | 2.3% | ||
| Q1 24 | 27.4% | 1.3% |
现金转化率
ASPN
CTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.14× | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPN
| Energy Industrial | $14.5M | 35% |
| Other | $13.9M | 34% |
| Thermal Barrier | $12.9M | 31% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |